ask="3.00"
ask_size="1500"
average_daily_volume="155226"
bid="2.01"
bid_size="100"
book_value="0.74"
change="-0.01"
change_from_200_day_moving_average="0.11"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-1.02"
change_From_52_week_low="1.34"
change_in_percent="-0.36%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="2.86"
high_52_weeks="3.82"
last_trade_date="2/7/2017"
last_trade_price="2.80"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.76"
low_52_weeks="1.46"
market_capitalization="95.61M"
moving_average_200_day="2.69"
moving_average_50_day="2.82"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="2.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.22%"
percent_change_from_50_day_moving_average="-0.82%"
percent_change_from_52_week_high="-26.70%"
percent_change_from_52_week_low="+91.78%"
previous_close="2.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.78"
price_per_sales="21.56"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.95"
stock_exchange="NGM"
symbol="FATE"
volume="45291"
weeks_range_52="1.46 - 3.82"
